Deutsche Bank’s Humacyte HUMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-168,628
Closed -$103K 3778
2026
Q1
$103K Buy
168,628
+59,876
+55% +$62.2K ﹤0.01% 3269
2025
Q4
$104K Buy
108,752
+7,666
+8% +$10.9K ﹤0.01% 3279
2025
Q3
$176K Buy
101,086
+12,258
+14% +$24K ﹤0.01% 3121
2025
Q2
$186K Buy
88,828
+19,071
+27% +$36.6K ﹤0.01% 3007
2025
Q1
$119K Sell
69,757
-8,717
-11% -$32.7K ﹤0.01% 3143
2024
Q4
$396K Buy
78,474
+26,419
+51% +$131K ﹤0.01% 2736
2024
Q3
$283K Buy
52,055
+31,363
+152% +$207K ﹤0.01% 2748
2024
Q2
$99.3K Sell
20,692
-7,650
-27% -$39.8K ﹤0.01% 3108
2024
Q1
$88.1K Sell
28,342
-1,128
-4% -$3.79K ﹤0.01% 3219
2023
Q4
$83.7K Sell
29,470
-1,858
-6% -$4.77K ﹤0.01% 3297
2023
Q3
$91.8K Sell
31,328
-291
-0.9% -$963 ﹤0.01% 3197
2023
Q2
$90.4K Sell
31,619
-9,122
-22% -$32.9K ﹤0.01% 3313
2023
Q1
$126K Buy
40,741
+15,406
+61% +$43.8K ﹤0.01% 3218
2022
Q4
$53.5K Buy
25,335
+18,172
+254% +$55.2K ﹤0.01% 3555
2022
Q3
$23K Sell
7,163
-1,180
-14% -$4.53K ﹤0.01% 3747
2022
Q2
$27K Buy
+8,343
New +$46.4K ﹤0.01% 3890

Other funds holding HUMA

Deutsche Bank's HUMA Position: Q2 2026 in Review

Deutsche Bank sold out of Humacyte (HUMA) in Q2 2026, closing a stake of 168,628 shares — an estimated $103K sold.

Deutsche Bank first reported a position in HUMA in Q2 2022 and held it in 16 quarters. The position peaked at $396K in Q4 2024. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Deutsche Bank reported no remaining Humacyte position as of Q2 2026 after selling out during the quarter.
  • Deutsche Bank sold 168,628 Humacyte shares in Q2 2026, an estimated $103K.
  • Deutsche Bank first reported a position in Humacyte in Q2 2022 and held it in 16 quarters.
  • Deutsche Bank's Humacyte position peaked at $396K in Q4 2024.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.